Previous in vivo studies demonstrated that free systemically administered tesa can reduce hypertriglyceridemia, hyperinsulinemia, and hyperglycemia in ob/ob mice and restore insulin sensitivity in obese Zucker rats [43]. The gene discussed is INS; the disease is Hyperinsulinemia.